These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31888921)

  • 1. Exclusion of Persons with Kidney Disease in Trials of Peripheral Artery Disease: A Systematic Review of Randomized Trials.
    Wen Y; Potok OA; Wei X; Paranjpe I; Chan L; Malhotra R; Coca S; Narula J; Olin JW; Nadkarni GN; Garimella PS
    Clin J Am Soc Nephrol; 2020 Jan; 15(1):117-119. PubMed ID: 31888921
    [No Abstract]   [Full Text] [Related]  

  • 2. Differences in patterns of peripheral arterial occlusive disease and eligibility for endovascular treatment.
    Zimmermann A; Arzt F; Wildgruber M; Schuster T; Wendorff H; Eckstein HH
    Vasa; 2012 Nov; 41(6):432-9. PubMed ID: 23129039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A meta-analysis of the outcome of endovascular and noninvasive therapies in the treatment of intermittent claudication.
    Ahimastos AA; Pappas EP; Buttner PG; Walker PJ; Kingwell BA; Golledge J
    J Vasc Surg; 2011 Nov; 54(5):1511-21. PubMed ID: 21958561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystatin C-based eGFR is a superior prognostic parameter to creatinine-based eGFR in post-endovascular therapy peripheral artery disease patients.
    Otaki Y; Takahashi H; Watanabe T; Yamaura G; Funayama A; Arimoto T; Shishido T; Miyamoto T; Kubota I
    Circ J; 2015; 79(11):2480-6. PubMed ID: 26354502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of severe chronic kidney disease on outcomes of infrainguinal peripheral arterial intervention.
    Patel VI; Mukhopadhyay S; Guest JM; Conrad MF; Watkins MT; Kwolek CJ; LaMuraglia GM; Cambria RP
    J Vasc Surg; 2014 Feb; 59(2):368-75. PubMed ID: 24176634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Use of Near Infrared Spectroscopy to Evaluate the Effect of Exercise on Peripheral Muscle Oxygenation in Patients with Lower Extremity Artery Disease: A Systematic Review.
    Cornelis N; Chatzinikolaou P; Buys R; Fourneau I; Claes J; Cornelissen V
    Eur J Vasc Endovasc Surg; 2021 May; 61(5):837-847. PubMed ID: 33810977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endovascular treatment for intermittent claudication in patients with peripheral arterial disease: a systematic review.
    Liu J; Wu Y; Li Z; Li W; Wang S
    Ann Vasc Surg; 2014 May; 28(4):977-82. PubMed ID: 24342830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eligibility of patients with peripheral arterial disease for participation in a community-based walking exercise program: a single-centre experience.
    Müller-Bühl U; Engeser P; Leutgeb R; Szecsenyi J
    Int Angiol; 2012 Oct; 31(5):462-7. PubMed ID: 22990509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACCF/AHA update peripheral artery disease management guideline.
    Hauk L
    Am Fam Physician; 2012 May; 85(10):1000-1. PubMed ID: 22612053
    [No Abstract]   [Full Text] [Related]  

  • 10. Perceived Versus Objective Change in Walking Ability in Peripheral Artery Disease: Results from 3 Randomized Clinical Trials of Exercise Therapy.
    McDermott MM; Tian L; Criqui MH; Ferrucci L; Greenland P; Guralnik JM; Kibbe MR; Li L; Sufit R; Zhao L; Polonsky TS
    J Am Heart Assoc; 2021 Jun; 10(12):e017609. PubMed ID: 34075780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of endovascular revascularization and supervised exercise therapy for intermittent claudication: a systematic review and meta-analysis.
    Klaphake S; Buettner S; Ultee KH; van Rijn MJ; Hoeks SE; Verhagen HJ
    J Cardiovasc Surg (Torino); 2018 Apr; 59(2):150-157. PubMed ID: 29327569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preexisting Conditions Determine the Occurrence of Unplanned Readmissions after Procedures for Treatment of Peripheral Arterial Disease.
    Aziz F; Lehman EB
    Ann Vasc Surg; 2018 Jul; 50():60-72. PubMed ID: 29481929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of including quality of life responses in models to predict walking performance of patients with intermittent claudication.
    Leicht AS; Crowther RG; Muller R; Golledge J
    Eur J Vasc Endovasc Surg; 2011 Apr; 41(4):511-7. PubMed ID: 21247784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Efficacy of Endovascular Revascularization Versus Supervised Exercise Training in Patients With Intermittent Claudication: Meta-Analysis of Randomized Controlled Trials.
    Pandey A; Banerjee S; Ngo C; Mody P; Marso SP; Brilakis ES; Armstrong EJ; Giri J; Bonaca MP; Pradhan A; Bavry AA; Kumbhani DJ
    JACC Cardiovasc Interv; 2017 Apr; 10(7):712-724. PubMed ID: 28385410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status of lower-extremity revascularization.
    Friedell ML; Stark KR; Kujath SW; Carter RR
    Curr Probl Surg; 2014 Jun; 51(6):254-90. PubMed ID: 24863077
    [No Abstract]   [Full Text] [Related]  

  • 17. A systematic review of randomized controlled trials: Walking versus alternative exercise prescription as treatment for intermittent claudication.
    Parmenter BJ; Raymond J; Dinnen P; Singh MA
    Atherosclerosis; 2011 Sep; 218(1):1-12. PubMed ID: 21601857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Level of disease and association with health status in patients presenting with claudication from the PORTRAIT registry.
    Vogel TR; Braet DJ; Kruse RL; Bath J; Wang J; Gosch K; Smolderen KG
    J Vasc Surg; 2020 Dec; 72(6):2017-2026. PubMed ID: 32325227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presentation, treatment, and outcome differences between men and women undergoing revascularization or amputation for lower extremity peripheral arterial disease.
    Lo RC; Bensley RP; Dahlberg SE; Matyal R; Hamdan AD; Wyers M; Chaikof EL; Schermerhorn ML
    J Vasc Surg; 2014 Feb; 59(2):409-418.e3. PubMed ID: 24080134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exercise training for health-related quality of life in peripheral artery disease: a systematic review and meta-analysis.
    Parmenter BJ; Dieberg G; Phipps G; Smart NA
    Vasc Med; 2015 Feb; 20(1):30-40. PubMed ID: 25432991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.